Recent investigations have converged on the overlap of GLP|GIP|GCGR activator therapies and DA neurotransmission. While GLP stimulators are widely employed for addressing type 2 diabetes, their unexpected effects on motivation circuits, specifically governed by dopaminergic networks, are attracting significant interest. This report provides a br… Read More